![Alex Fotopoulos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Alex Fotopoulos formerly worked at Biogen, Inc., as Senior Director-Global Manufacturing Engineering from 1994 to 2011, Momenta Pharmaceuticals, Inc., as Vice President-Technical Operations from 2011 to 2016, Ultragenyx Pharmaceutical, Inc., as Senior Vice President-Technical Operations from 2017 to 2019, Dimension Therapeutics, Inc., as Senior Vice President & Head-Technical Operations from 2016 to 2017, and Passage Bio, Inc., as Chief Technical Officer from 2019 to 2023.
Mr. Fotopoulos received his graduate degree in 1997 from Tufts University and Masters Business Admin degree in 1998 from F.W.
Olin Graduate School of Business.
Eerdere bekende functies van Alex Fotopoulos
| Bedrijven | Functie | Einde |
|---|---|---|
| PASSAGE BIO, INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2023 |
| ULTRAGENYX PHARMACEUTICAL INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2019 |
| DIMENSION THERAPEUTICS INC | Hoofd Techniek/Wetenschap/O&O | 01-11-2017 |
| MOMENTA PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2016 |
| BIOGEN INC. | Corporate Officer/Principal | 01-01-2011 |
Opleiding van Alex Fotopoulos
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
83
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for rare diseases | Health Technology |
F.W. Olin Graduate School of Business
 F.W. Olin Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Kies MarketScreener 
